Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - CYTOKINETICS INC | cytk-ex321_10.htm |
| EX-31.3 - EX-31.3 - CYTOKINETICS INC | cytk-ex313_12.htm |
| EX-31.2 - EX-31.2 - CYTOKINETICS INC | cytk-ex312_11.htm |
| EX-31.1 - EX-31.1 - CYTOKINETICS INC | cytk-ex311_14.htm |
| EX-4.8 - EX-4.8 - CYTOKINETICS INC | cytk-ex48_152.htm |
| 10-K - 10-K - CYTOKINETICS INC | cytk-10k_20191231.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the following Registration Statements:
|
|
1) |
Forms S-3 (Nos. 333-215147, 333-221350, 333-231348 and 333-234537), and |
|
|
2) |
Forms S-8 (Nos. 333-115146, 333-125973, 333-133323, 333-136524, 333-140963, 333-149713, 333-152850, 333-161116, 333-168520, 333-176089, 333-183091, 333-190458, 333-206101, and 333-221348) pertaining to the Amended and Restated 2004 Equity Incentive Plan of Cytokinetics, Incorporated; |
of our reports dated March 4, 2020, with respect to the consolidated financial statements of Cytokinetics, Incorporated and the effectiveness of internal control over financial reporting of Cytokinetics, Incorporated included in this Annual Report (Form 10-K) of Cytokinetics, Incorporated for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Redwood City, California
March 4, 2020